United-Guardian(UG) - 2024 Q2 - Quarterly Results

Sales Performance - Sales for the first half of 2024 increased by 27.3% to $6,645,149 compared to$5,220,623 in 2023[1] - Second quarter sales increased by 28% to $3,390,205 from$2,650,299 in the same quarter of 2023[1] - Cosmetic ingredient sales surged by 84% in the second quarter and 115% for the first six months of 2024[2] - Medical lubricant sales increased by 15% in the second quarter and 9% for the first half of 2024[2] - Pharmaceutical product sales decreased by 13% for the first six months of 2024 due to a shutdown of the contract manufacturer for Renacidin[2] - Renacidin production resumed in late March 2024, with sales recovering[2] Net Income and Earnings - Net income for the first half of 2024 rose by 54.5% to $1,881,667 ($0.41 per share) from $1,217,175 ($0.26 per share) in 2023[1] - Earnings per share for the second quarter increased to $0.21 from$0.10 in 2023[5] Other Income and Shares - Total other income for the first half of 2024 was $230,075, compared to$182,762 in 2023[5] - The weighted average shares outstanding remained constant at 4,594,319 for both periods[5]